A comprehensive view of novavax inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novavax Inc. Files SEC Form 8-K, Current Report: (Nov. 21, 2022)

Novavax narrows revenue projection as uptake of its COVID vaccine continues to lag; firm projects annual US COVID-19 booster market will include about 225 million people

World Health Organization updates emergency use listing for Novavax Nuvaxovid COVID-19 vaccine as a primary series in adolescents and as a booster in adults

Novavax ends supply deal with Gavi, the Vaccine Alliance, after Gavi fails to buy 350 million vaccine doses for low-, middle-income countries

Wells Fargo: Pfizer's plan to quadruple current COVID-19 vaccine prices for US to US$110-US$130/dose in 2023 could add about US$2.5B-US$3B in annual dosing revenue; announcement could be green light for Moderna, Novavax to raise their prices in same range

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count